Prescription Required
Caution is advised when consuming alcohol with Virocomb N 150 mg/300 mg/200 mg Tablet. Please consult your doctor.
Virocomb N 150 mg/300 mg/200 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Virocomb N 150 mg/300 mg/200 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Virocomb N 150 mg/300 mg/200 mg Tablet may cause side effects which could affect your ability to drive.<BR>You may experience fatigue while taking Virocomb N 150 mg/300 mg/200 mg Tablet and this may affect your ability to drive.
Virocomb N 150 mg/300 mg/200 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Virocomb N 150 mg/300 mg/200 mg Tablet may be needed. Please consult your doctor.
Virocomb N 150 mg/300 mg/200 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Virocomb N 150 mg/300 mg/200 mg Tablet may be needed. Please consult your doctor.<BR>Use of Virocomb N 150 mg/300 mg/200 mg Tablet is not recommended in patients with moderate to severe liver disease. Regular monitoring of liver function tests is advised while you are taking this medicine.
Virocomb N 150 mg/300 mg/200 mg Tablet is a combination of three antiviral medicines: Lamivudine, Zidovudine and Nevirapine. They work by preventing HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.
Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA